UBS AM’s Arrowhead Research ARWR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.6M | Sell |
964,479
-366,517
| -28% | -$27.1M | 0.01% | 562 |
|
|
2026
Q1 | $83.5M | Buy |
1,330,996
+70,616
| +6% | +$4.47M | 0.02% | 541 |
|
|
2025
Q4 | $83.7M | Sell |
1,260,380
-499,109
| -28% | -$24.5M | 0.02% | 524 |
|
|
2025
Q3 | $60.7M | Sell |
1,759,489
-924,828
| -34% | -$20.3M | 0.01% | 569 |
|
|
2025
Q2 | $42.4M | Sell |
2,684,317
-2,100,745
| -44% | -$30.1M | 0.01% | 746 |
|
|
2025
Q1 | $61M | Buy |
4,785,062
+2,774,933
| +138% | +$50.5M | 0.02% | 643 |
|
|
2024
Q4 | $37.8M | Sell |
2,010,129
-144,121
| -7% | -$2.97M | 0.01% | 735 |
|
|
2024
Q3 | $41.7M | Sell |
2,154,250
-135,904
| -6% | -$3.32M | 0.01% | 712 |
|
|
2024
Q2 | $59.5M | Buy |
2,290,154
+1,356,254
| +145% | +$33.3M | 0.02% | 572 |
|
|
2024
Q1 | $26.7M | Sell |
933,900
-17,394
| -2% | -$556K | 0.01% | 717 |
|
|
2023
Q4 | $29.1M | Buy |
951,294
+210,412
| +28% | +$5.59M | 0.01% | 701 |
|
|
2023
Q3 | $19.9M | Buy |
740,882
+203,917
| +38% | +$6.25M | 0.01% | 763 |
|
|
2023
Q2 | $13.6M | Hold |
536,965
| – | – | 0.01% | 860 |
|
|
2023
Q1 | $13.6M | Buy |
536,965
+39,044
| +8% | +$1.23M | 0.01% | 860 |
|
|
2022
Q4 | $20.2M | Buy |
497,921
+411,561
| +477% | +$13.6M | 0.01% | 756 |
|
|
2022
Q3 | $2.85M | Sell |
86,360
-23,365
| -21% | -$943K | ﹤0.01% | 1414 |
|
|
2022
Q2 | $3.86M | Sell |
109,725
-4,161
| -4% | -$157K | ﹤0.01% | 1311 |
|
|
2022
Q1 | $5.24M | Buy |
113,886
+16,777
| +17% | +$831K | ﹤0.01% | 1334 |
|
|
2021
Q4 | $6.44M | Sell |
97,109
-1,383
| -1% | -$95K | ﹤0.01% | 1300 |
|
|
2021
Q3 | $6.15M | Buy |
98,492
+10,831
| +12% | +$701K | ﹤0.01% | 1270 |
|
|
2021
Q2 | $7.26M | Sell |
87,661
-3,800
| -4% | -$283K | ﹤0.01% | 1226 |
|
|
2021
Q1 | $6.06M | Sell |
91,461
-26,135
| -22% | -$2.03M | ﹤0.01% | 1265 |
|
|
2020
Q4 | $9.02M | Buy |
117,596
+11,477
| +11% | +$734K | ﹤0.01% | 1094 |
|
|
2020
Q3 | $4.57M | Buy |
106,119
+945
| +0.9% | +$40.8K | ﹤0.01% | 1188 |
|
|
2020
Q2 | $4.54M | Buy |
105,174
+16,277
| +18% | +$574K | ﹤0.01% | 1154 |
|
|
2020
Q1 | $2.56M | Sell |
88,897
-1,197
| -1% | -$48.3K | ﹤0.01% | 1318 |
|
|
2019
Q4 | $5.71M | Sell |
90,094
-1,037
| -1% | -$51.5K | ﹤0.01% | 1140 |
|
|
2019
Q3 | $2.57M | Buy |
91,131
+13,814
| +18% | +$409K | ﹤0.01% | 1490 |
|
|
2019
Q2 | $2.05M | Buy |
77,317
+36,142
| +88% | +$793K | ﹤0.01% | 1578 |
|
|
2019
Q1 | $756K | Sell |
41,175
-14,089
| -25% | -$232K | ﹤0.01% | 1931 |
|
|
2018
Q4 | $686K | Sell |
55,264
-12,002
| -18% | -$164K | ﹤0.01% | 1873 |
|
|
2018
Q3 | $1.29M | Buy |
67,266
+18,184
| +37% | +$298K | ﹤0.01% | 1706 |
|
|
2018
Q2 | $668K | Buy |
+49,082
| New | +$459K | ﹤0.01% | 1977 |
|
|
2017
Q2 | – | Sell |
-66,400
| Closed | -$123K | – | 2532 |
|
|
2017
Q1 | $123K | Buy |
66,400
+53,500
| +415% | +$106K | ﹤0.01% | 2275 |
|
|
2016
Q4 | $20K | Sell |
12,900
-10,900
| -46% | -$46.4K | ﹤0.01% | 2352 |
|
|
2016
Q3 | $175K | Hold |
23,800
| – | – | ﹤0.01% | 2496 |
|
|
2016
Q2 | $127K | Hold |
23,800
| – | – | ﹤0.01% | 2556 |
|
|
2016
Q1 | $115K | Sell |
23,800
-15,600
| -40% | -$65.8K | ﹤0.01% | 2549 |
|
|
2015
Q4 | $242K | Buy |
39,400
+3,500
| +10% | +$19.8K | ﹤0.01% | 2445 |
|
|
2015
Q3 | $207K | Buy |
35,900
+14,700
| +69% | +$92.4K | ﹤0.01% | 2479 |
|
|
2015
Q2 | $152K | Hold |
21,200
| – | – | ﹤0.01% | 2637 |
|
|
2015
Q1 | $143K | Buy |
21,200
+1,400
| +7% | +$9.94K | ﹤0.01% | 2545 |
|
|
2014
Q4 | $146K | Buy |
19,800
+5,200
| +36% | +$35.4K | ﹤0.01% | 2530 |
|
|
2014
Q3 | $216K | Buy |
14,600
+900
| +7% | +$12.3K | ﹤0.01% | 2328 |
|
|
2014
Q2 | $196K | Buy |
+13,700
| New | +$180K | ﹤0.01% | 2418 |
|
Other funds holding ARWR
ACA
FAM
UBS AM's ARWR Position: Q2 2026 in Review
UBS AM reduced its Arrowhead Research (ARWR) stake by 28% in Q2 2026, selling an estimated $27.1M and leaving 964,479 shares worth $78.6M. The position accounts for 0.01% of the portfolio, ranked #562.
UBS AM first reported a position in ARWR in Q2 2014 and has held it in 45 quarters since. The position peaked at $83.7M in Q4 2025. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.
- UBS AM held 964,479 shares of Arrowhead Research worth $78.6M as of Q2 2026.
- UBS AM sold 366,517 Arrowhead Research shares in Q2 2026, an estimated $27.1M.
- Arrowhead Research made up 0.01% of UBS AM's portfolio in Q2 2026, its #562 holding.
- UBS AM first reported a position in Arrowhead Research in Q2 2014 and has held it in 45 quarters since.
- UBS AM's Arrowhead Research position peaked at $83.7M in Q4 2025.
- 500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.